Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
about
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunityInterferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cellsPolymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosusCross-regulation of TNF and IFN-alpha in autoimmune diseasesA natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunityMicroarray analysis of gene expression in lupusInterpreting interest in interferon-alphaTargeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayBreakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic CellsSLE-associated risk factors affect DC functionLinking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosusThe antigen presenting cells instruct plasma cell differentiationIntracellular nucleic acid sensors and autoimmunityTLRs and interferons: a central paradigm in autoimmunitySexual dimorphism in autoimmunityRole of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunityEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaTLR ligands up-regulate Trex1 expression in murine conventional dendritic cells through type I Interferon and NF-κB-dependent signaling pathwaysThe pathogenesis of systemic lupus erythematosus—an updateThe role of dendritic cells in autoimmunityType I interferon receptor deficiency prevents murine Sjogren's syndromeDistinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axisAim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility proteinAim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus.Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha.TLRs and IFNs: critical pieces of the autoimmunity puzzleAutoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signalingStage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus.Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity.Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside.New roles for the major human 3'-5' exonuclease TREX1 in human disease.Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesA genomic approach to human autoimmune diseases.Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus
P2860
Q22306446-71D4984F-7F95-4551-AB82-B3D7CABC6114Q24323367-F3E72012-09FD-4997-B058-078D17D7F90FQ24530690-1CD8EB19-4EC8-4FF6-8417-363A23A6D401Q24556513-CF5DAF15-FC46-48F9-A829-74D9CB6B9D5CQ24673016-42878B71-0109-443B-BACC-559408A594FBQ24795089-27BC8218-25F4-4630-AFEF-729EB37FAB29Q24797820-2C4DFB19-3D26-4344-8E51-B5D03212B67DQ26746697-83D49267-429E-4390-B565-DEB228B61B5DQ26748941-B32B673D-D179-41C2-9437-8C51945543C8Q26774797-9F191439-C1C5-4AF8-A7E4-BCDE61C6CFC3Q26822662-97CF980E-94B0-4DD6-BEF5-7EA172804474Q26995780-7CE8C09B-579D-49E4-AC10-740F17E7352CQ26997316-70905FA4-FAA9-4601-8C90-211DB30C03F0Q27023982-057D3164-B72A-4788-A570-9553BF51CECCQ28080459-318E2C27-32DF-44A7-81A0-C1325965FE6CQ28246851-C7CA7BEA-BC03-46B5-9BBB-6DB85C78A1E8Q28265144-5064A717-0B96-4585-B750-22488DA8C857Q28510527-B479B808-0B5E-415F-9D97-9DD9F1A133C1Q29394347-DD2B7A20-83EC-443B-AACD-71A217F2A73BQ30047565-5413E04E-734A-4AE5-89A3-B12149F6D0E3Q30413385-06F88F29-95E2-47F3-82AF-9DB8C5727835Q30423162-6ACC46EA-8F3B-4F93-9BF0-A7EB9D0EBE24Q30426448-A1A452F4-5E59-4F5C-88C4-FF61A880962FQ30429300-B0C76330-3B1B-4D6D-BB90-8535E620C278Q31080044-10F4CC48-976F-4E64-9639-4871306D48B3Q33334070-94BAB738-903D-4FD3-9210-6D66799F9712Q33354714-AE42EACA-0E8E-4D13-977A-A5EB9BA6BB8FQ33423646-1D7C8816-A389-4F3F-8F08-532540B88EA0Q33496779-13178C77-733E-4620-8412-C43088DB4ED1Q33595836-0EC5DCBB-C115-4EA7-97DF-544E778FBAAAQ33605468-7A560B8C-590E-4FF8-AC0D-15A48678851EQ33606019-E0E73BD2-E649-4F6B-A931-A8B7C0C28E80Q33622723-43A43EF3-C53B-4444-BD5C-35D261F3D3B9Q33671295-C792BA10-E4A1-4807-AAAD-CA223AFE3B3CQ33694922-2AD253A1-E64A-456B-9B02-BD1E1BE26A8AQ33731760-4AC65B44-C403-4E07-9B58-6E7CBBBEF71CQ33733803-DE831293-EC83-465B-BA22-D2B38BA48E2BQ33762839-EC4FD3DF-8AE3-4A0E-89DF-7A7B5FF989E7Q33790174-58A09910-75D1-41E5-B949-7B0217D0F6B1Q33804141-18EDA02D-9072-422A-A692-C0CDC48ABB3A
P2860
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
@ast
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
@en
type
label
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
@ast
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
@en
prefLabel
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
@ast
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
@en
P2093
P2860
P356
P1476
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
@en
P2093
Argyrios N Theofilopoulos
Divaker Choubey
Dwight H Kono
Katarina M Haraldsson
Marie-Laure Santiago-Raber
Roberto Baccala
Timothy A Stewart
P2860
P304
P356
10.1084/JEM.20021996
P407
P577
2003-03-01T00:00:00Z